Hi MM,
I think there is little doubt that psychedelics is going to be a game changer for IHL.
It would be really good for IHL to come out and give us some details of their plan/strategy in relation to the development and commercialisation of their psychedelics program.
Taking on Dr Paul Liknaitsky is a fair clue of their intention to exploit the psychedelics market, but some confirmation in terms of a formal announcement would be huge.
- Forums
- ASX - By Stock
- IHL
- Ann: Positive IHL-675A in vivo results and FDA Pathway
Ann: Positive IHL-675A in vivo results and FDA Pathway, page-112
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IHL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online